| For: | Lee J, Yekula A, Wexler A, Zhuang W, Elangovan A, Rosario J, Burger P, Ramaraju G, Addissie B, Lim N, Narkewicz MR, Twohig P. Liver injury in cystic fibrosis: How to distinguish drug-induced liver injury from cystic fibrosis liver disease? World J Gastroenterol 2026; 32(10): 114946 [PMID: 41809454 DOI: 10.3748/wjg.v32.i10.114946] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v32/i10/114946.htm |
| Number | Citing Articles |
| 1 |
Clara Laffitte Redondo, Venceslas Bourdin, Abd El Kader Ait Tayeb, Sihem Benaboud, Inès Martins, Caroline Joyau, Myriam Benhamida, Isabelle Sermet‐Gaudelus, Clémence Martin, Pierre Régis Burgel, Céline Verstuyft, Laurent Chouchana, Estelle Ayme‐Dietrich. A descriptive case series of hepatotoxicity associated with CFTR modulators and possible relevance of pharmacogenetic polymorphisms in cystic fibrosis patients. British Journal of Clinical Pharmacology 2026; doi: 10.1002/bcp.70660
|
| 2 |
Z.M. Merzhoeva, Yu.A. Levina, B.B. Lavginova, O.A. Suvorova, V.N. Antonov, S.N. Avdeev. Case of targeted therapy in a patient with cystic fibrosis and decompensated liver cirrhosis. Journal of Respiratory Medicine 2026; 2(2) doi: 10.17116/respmed2026202166
|